Comparing Approaches to Helping People With Chronic Traumatic Brain Injury Manage Their Health Care

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorIndiana University

About this trial

The goal of this double-masked, randomized control trial is to learn about the potential benefits of two different strategies at helping people with traumatic brain injury who see a brain injury physician be more engaged in their healthcare and feel more confident in managing their health.

The main questions it aims to answer are:

* When comparing the two strategies, which will result in high participant-reported health empowerment assessed approximately 7 - 21 days of completing the approach? * When comparing the two strategies, which will result in high participant-reported health engagement assessed approximately 7 - 21 days of completing the approach?

Participants will:

* complete baseline assessments about their health, daily activities, and their attitudes about healthcare and their treatment. These will be done over the phone and/or online survey. * have one virtual session with a health professional to discuss their health and wellness. * 7-21 days after the session with a health professional, participants will complete an online survey about their attitudes about healthcare and their treatment. * Some participants may be invited to complete an additional interview about their study participation around 3 months after their session with the health professional.

Eligibility criteria

Qualifiers

community dwelling adult (>18 years at enrollment)

≥1-year post-TBI of any severity based on The Ohio State University-TBI Identification Method

followed by a brain injury physician for TBI care who refers them to the study

must have sufficient comprehension, communication, sensorimotor function, and English proficiency (due to outcome measures not being validated in languages other than English)

Disqualifiers

non-community dwelling

Trial design

Treatments tested in this trial

  • Patient Priorities Care (PPC)
  • Resource Education

Treatment groups

142 Participants
are divided into 2 treatment groups

Sponsors and collaborators